Transcriptional regulation of the AP-1 and Nrf2 target gene sulfiredoxin

Molecules and Cells

Volumn 27, Issue 3, 2009, Pages 279-282

  Soriano, Francesc X ^a   Baxter, Paul ^a   Murray, Lyndsay M ^a   Sporn, Michael B ^b   Gillingwater, Thomas H ^a   Hardingham, Giles E ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Antioxidant response element; AP 1; Nrf2; Oxidative stress; Peroxiredoxin; Sulfiredoxin

Indexed keywords

(2 CYANO 3,12 DIOXOOLEANA 1,9 DIEN 28 OIC ACID)TRIFLUOROETHYLAMIDE; ANTIOXIDANT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PEROXIREDOXIN; SULFIREDOXIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NRF2; TRITERPENOID; UNCLASSIFIED DRUG; OXIDOREDUCTASE; SRXN1 PROTEIN, HUMAN; SULFIREDOXIN PROTEIN, MOUSE;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIOXIDANT RESPONSIVE ELEMENT; CARCINOGENESIS; CELL PROTECTION; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HYPEROXIA; NERVE CELL; NONHUMAN; OXIDATIVE STRESS; PEROXIDATION; PROMOTER REGION; SHORT SURVEY; SYNAPTIC POTENTIAL; TRANSCRIPTION REGULATION; UPREGULATION; ANIMAL; GENETICS; METABOLISM; MOUSE; NUCLEOTIDE SEQUENCE; REVIEW; TRANSCRIPTION INITIATION;

ANIMALS; BASE SEQUENCE; HUMANS; MICE; NF-E2-RELATED FACTOR 2; OXIDOREDUCTASES ACTING ON SULFUR GROUP DONORS; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTIONAL ACTIVATION;

EID: 70349311825     PISSN: 10168478     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10059-009-0050-y     Document Type: Short Survey

References (36)

1. Bae, S.H., Woo, H.A., Sung, S.H., Lee, H.E., Lee, S.K., Kil, I.S., and Rhee, S.G. (2009). Induction of sulfiredoxin via an Nrf2- dependent pathway and hyperoxidation of peroxiredoxin III in the lungs of mice exposed to hyperoxia. Antioxid. Redox Signal. [Epub ahead of print]
2. B. Biteau J. Labarre M.B. Toledano 2003 ATP-dependent reduction of cysteine-sulphinic acid by S. cerevisiae sulphiredoxin Nature 425 980 984 14586471 10.1038/nature02075 1:CAS:528:DC%2BD3sXosVOht7k%3D (Pubitemid 37376931)
3. S. Boulos B.P. Meloni P.G. Arthur C. Bojarski N.W. Knuckey 2007 Peroxiredoxin 2 overexpression protects cortical neuronal cultures from ischemic and oxidative injury but not glutamate excitotoxicity, whereas Cu/Zn superoxide dismutase 1 overexpression protects only against oxidative injury J. Neurosci. Res. 85 3089 3097 17663478 10.1002/jnr.21429 1:CAS:528:DC%2BD2sXhtlGmsrbK (Pubitemid 350057364)
4. P.H. Brown R. Alani L.H. Preis E. Szabo M.J. Birrer 1993 Suppression of oncogene-induced transformation by a deletion mutant of c-jun Oncogene 8 877 886 8455942 1:CAS:528:DyaK3sXktVKjtL4%3D
5. A.V. Budanov A.A. Sablina E. Feinstein E.V. Koonin P.M. Chumakov 2004 Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD Science 304 596 600 15105503 10.1126/science.1095569 1:CAS:528: DC%2BD2cXjt1Crsro%3D (Pubitemid 38541920)
6. T.S. Chang W. Jeong H.A. Woo S.M. Lee S. Park S.G. Rhee 2004 Characterization of mammalian sulfiredoxin and its reactivation of hyperoxidized peroxiredoxin through reduction of cysteine sulfinic acid in the active site to cysteine J. Biol. Chem. 279 50994 51001 15448164 10.1074/jbc.M409482200 1:CAS:528:DC%2BD2cXhtVaqsr%2FP (Pubitemid 40017840)
7. J. Fang T. Nakamura D.H. Cho Z. Gu S.A. Lipton 2007 S-nitrosylation of peroxiredoxin 2 promotes oxidative stressinduced neuronal cell death in Parkinson's disease Proc. Natl. Acad. Sci. USA 104 18742 18747 18003920 10.1073/pnas.0705904104 1:CAS:528:DC%2BD2sXhtl2lsbnE (Pubitemid 350210767)
8. V.J. Findlay D.M. Townsend T.E. Morris J.P. Fraser L. He K.D. Tew 2006 A novel role for human sulfiredoxin in the reversal of glutathionylation Cancer Res. 66 6800 6806 16818657 10.1158/0008-5472.CAN-06-0484 1:CAS:528: DC%2BD28XmsVals7k%3D (Pubitemid 44085640)
9. A. Giudice M. Montella 2006 Activation of the Nrf2-ARE signaling pathway: a promising strategy in cancer prevention Bioessays 28 169 181 16435293 10.1002/bies.20359 1:CAS:528:DC%2BD28XitVCkt7w%3D (Pubitemid 43294789)
10. D.A. Glauser T. Brun B.R. Gauthier W. Schlegel 2007 Transcriptional response of pancreatic beta cells to metabolic stimulation: large scale identification of immediate-early and secondary response genes BMC Mol. Biol. 8 54 17587450 10.1186/1471-2199-8-54 (Pubitemid 47225316)
11. F. Hattori N. Murayama T. Noshita S. Oikawa 2003 Mitochondrial peroxiredoxin-3 protects hippocampal neurons from excitotoxic injury in vivo J. Neurochem. 86 860 868 12887684 10.1046/j.1471-4159.2003.01918.x 1:CAS:528:DC%2BD3sXmslOgsL4%3D (Pubitemid 36988798)
12. S. Immenschuh E. Baumgart-Vogt 2005 Peroxiredoxins, oxidative stress, and cell proliferation Antioxid. Redox Signal. 77 768 777 10.1089/ars.2005.7.768 (Pubitemid 40563217)
13. W. Jeong S.J. Park T.S. Chang D.Y. Lee S.G. Rhee 2006 Molecular mechanism of the reduction of cysteine sulfinic acid of peroxiredoxin to cysteine by mammalian sulfiredoxin J. Biol. Chem. 281 14400 14407 16565085 10.1074/jbc.M511082200 1:CAS:528:DC%2BD28XksFeit7w%3D (Pubitemid 43848370)
14. T.J. Jonsson L.C. Johnson W.T. Lowther 2008 Structure of the sulphiredoxin-peroxiredoxin complex reveals an essential repair embrace Nature 451 98 101 18172504 10.1038/nature06415
15. T.J. Jonsson M.S. Murray L.C. Johnson W.T. Lowther 2008 Reduction of cysteine sulfinic acid in peroxiredoxin by sulfiredoxin proceeds directly through a sulfinic phosphoryl ester intermediate J. Biol. Chem. 283 23846 23851 18579529 10.1074/jbc.M803244200
16. T.W. Kensler N. Wakabayashi S. Biswal 2007 Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway Annu. Rev. Pharmacol. Toxicol. 47 89 116 16968214 10.1146/annurev.pharmtox.46.120604.141046 1:CAS:528:DC%2BD2sXit1altrg%3D (Pubitemid 46272125)
17. J.M. Lee J. Li D.A. Johnson T.D. Stein A.D. Kraft M.J. Calkins R.J. Jakel J.A. Johnson 2005 Nrf2, a multi-organ protector? FASEB J. 19 1061 1066 15985529 10.1096/fj.04-2591hyp (Pubitemid 40946431)
18. K.T. Liby M.M. Yore M.B. Sporn 2007 Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer Nat. Rev. Cancer 7 357 369 17446857 10.1038/nrc2129 1:CAS:528:DC%2BD2sXksFSiu7g%3D (Pubitemid 46652485)
19. T. Nguyen C.S. Yang C.B. Pickett 2004 The pathways and molecular mechanisms regulating Nrf2 activation in response to chemical stress Free Radic. Biol. Med. 37 433 441 15256215 10.1016/j.freeradbiomed.2004.04.033 1:CAS:528:DC%2BD2cXlsl2nu7g%3D (Pubitemid 38901076)
20. P. Nioi M. McMahon K. Itoh M. Yamamoto J.D. Hayes 2003 Identification of a novel Nrf2-regulated antioxidant response element (ARE) in the mouse NAD(P)H:quinone oxidoreductase 1 gene: reassessment of the ARE consensus sequence Biochem. J. 374 337 348 12816537 10.1042/BJ20030754 1:CAS:528:DC%2BD3sXms1Gks7o%3D (Pubitemid 37094093)
21. Noh, Y.H., Baek, J.Y., Jeong, W., Rhee, S.G., and Chang, T.S. (2009). Sulfiredoxin translocation into mitochondria plays a crucial role in reducing hyperoxidized peroxiredoxin III. J. Biol. Chem. doi:10.1074/jbc.M808981200.
22. S. Papadia F.X. Soriano F. Leveille M.A. Martel K.A. Dakin H.H. Hansen A. Kaindl M. Sifringer J. Fowler V. Stefovska, et al. 2008 Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses Nat. Neurosci. 11 476 487 18344994 10.1038/nn2071 1:CAS:528:DC%2BD1cXjslSrt70%3D
23. D. Qu J. Rashidian M.P. Mount H. Aleyasin M. Parsanejad A. Lira E. Haque Y. Zhang S. Callaghan M. Daigle, et al. 2007 Role of Cdk5-mediated phosphorylation of Prx2 in MPTP toxicity and Parkinson's disease Neuron 55 37 52 17610816 10.1016/j.neuron.2007.05.033 1:CAS:528:DC%2BD2sXot1eltro%3D (Pubitemid 46990825)
24. S.G. Rhee H.Z. Chae K. Kim 2005 Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling Free Radic. Biol. Med. 38 1543 1552 15917183 10.1016/j.freeradbiomed.2005.02. 026 1:CAS:528:DC%2BD2MXks1WhurY%3D (Pubitemid 40726061)
25. S.G. Rhee W. Jeong T.S. Chang H.A. Woo 2007 Sulfiredoxin, the cysteine sulfinic acid reductase specific to 2-Cys peroxiredoxin: its discovery, mechanism of action, and biological significance Kidney Int. 106 S3 8 10.1038/sj.ki.5002380 1:CAS:528:DC%2BD2sXotFyltro%3D (Pubitemid 47172555)
26. S.G. Rhee H.A. Woo S.H. Bae S. Park 2009 Sestrin 2 is not a reductase for cysteine sulfinic acid of peroxiredoxins Antioxid. Redox Signal. 11 739 745 10.1089/ars.2008.2360
27. M.F. Sanchez-Font J. Sebastia C. Sanfeliu R. Cristofol G. Marfany R. Gonzalez-Duarte 2003 Peroxiredoxin 2 (PRDX2), an antioxidant enzyme, is under-expressed in Down syndrome fetal brains Cell Mol. Life Sci. 60 1513 1523 12943237 10.1007/s00018-003-3048-1 1:CAS:528:DC%2BD3sXms1Wit7w%3D (Pubitemid 36900532)
28. A.Y. Shih P. Li T.H. Murphy 2005 A small-molecule-inducible Nrf2-mediated antioxidant response provides effective prophylaxis against cerebral ischemia in vivo J. Neurosci. 25 10321 10335 16267240 10.1523/JNEUROSCI.4014-05.2005 1:CAS:528:DC%2BD2MXht1Wqt7%2FF (Pubitemid 41636229)
29. A. Singh G. Ling A.N. Suhasini P. Zhang M. Yamamoto A. Navas-Acien G. Cosgrove R.M. Tuder T.W. Kensler W.H. Watson, et al. 2009 Nrf2-dependent sulfiredoxin-1 expression protects against cigarette smoke-induced oxidative stress in lungs Free Radic. Biol. Med. 46 376 386 19027064 10.1016/j. freeradbiomed.2008.10.026 1:CAS:528:DC%2BD1MXht1Wmtg%3D%3D
30. F.X. Soriano F. Leveille S. Papadia L.G. Higgins J. Varley P. Baxter J.D. Hayes G.E. Hardingham 2008 Induction of sulfiredoxin expression and reduction of peroxiredoxin hyperoxidation by the neuroprotective Nrf2 activator 3H-1,2-dithiole-3-thione J. Neurochem. 107 533 543 18761713 10.1111/j.1471-4159. 2008.05648.x 1:CAS:528:DC%2BD1cXhtlajtbvP
31. W.W. Wasserman W.E. Fahl 1997 Comprehensive analysis of proteins which interact with the antioxidant responsive element: correlation of ARE-BP-1 with the chemoprotective induction response Arch. Biochem. Biophys. 344 387 396 9264553 10.1006/abbi.1997.0215 1:CAS:528:DyaK2sXlsVGqsbY%3D (Pubitemid 27344076)
32. Q. Wei H. Jiang C.P. Matthews N.H. Colburn 2008 Sulfiredoxin is an AP-1 target gene that is required for transformation and shows elevated expression in human skin malignancies Proc. Natl. Acad. Sci. USA 105 19738 19743 19057013 10.1073/pnas.0810676105 1:CAS:528:DC%2BD1cXhsFCltrrO
33. Z.A. Wood E. Schroder J. Robin Harris L.B. Poole 2003 Structure, mechanism and regulation of peroxiredoxins Trends Biochem. Sci. 28 32 40 12517450 10.1016/S0968-0004(02)00003-8 1:CAS:528:DC%2BD3sXnvFGh (Pubitemid 36051004)
34. Yao, J., Taylor, M., Davey, F., Ren, Y., Aiton, J., Coote, P., Fang, F., Chen, J.X., Yan, S.D., and Gunn-Moore, F.J. (2007). Interaction of amyloid binding alcohol dehydrogenase/Abeta mediates up-regulation of peroxiredoxin II in the brains of Alzheimer's disease patients and a transgenic Alzheimer's disease mouse model. Mol. Cell. Neurosci., 377-382.
35. M.S. Yates M. Tauchi F. Katsuoka K.C. Flanders K.T. Liby T. Honda G.W. Gribble D.A. Johnson J.A. Johnson N.C. Burton, et al. 2007 Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes Mol. Cancer Ther. 6 154 162 17237276 10.1158/1535-7163.MCT-06-0516 1:CAS:528:DC%2BD2sXmsVamsA%3D%3D (Pubitemid 46206678)
36. D.D. Zhang 2006 Mechanistic studies of the Nrf2-Keap1 signaling pathway Drug Metab. Rev. 38 769 789 17145701 10.1080/03602530600971974 1:CAS:528:DC%2BD28XhtlCnur%2FP (Pubitemid 44903268)